Effect of a therapeutic maximum allowable cost (MAC) program on the cost and utilization of proton pump inhibitors in an employer-sponsored drug plan in Canada (Q36515302)
Jump to navigation
Jump to search
scientific article published on June 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of a therapeutic maximum allowable cost (MAC) program on the cost and utilization of proton pump inhibitors in an employer-sponsored drug plan in Canada |
scientific article published on June 2006 |
Statements
1 reference
Effect of a therapeutic maximum allowable cost (MAC) program on the cost and utilization of proton pump inhibitors in an employer-sponsored drug plan in Canada (English)
1 reference
Vincent H Mabasa
1 reference
Johnny Ma
1 reference
1 reference